Evaluation Of Antimicrobial Drug (antibiotic, Antifungal, Antiviral) in North Carolina
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in North Carolina
| Provider | Medicare | Services |
|---|---|---|
| Whitmore, Robert MD | $7.24 | 141 |
| Andor Labs | $7.33 | 60 |
| Wardell, Walter M.D. | $7.33 | 59 |
| Moeller, Mark MD | $7.33 | 57 |
| Reardon, Michael MD | $7.33 | 51 |
| Laboratory Corporation Of America... | $7.33 | 50 |
| Farina, Nicholas MD | $7.33 | 36 |
| Johnson, Susannah MD | $7.33 | 34 |
| Holmes, Robert D.O. | $7.33 | 33 |
| Jasper, John M.D. | $7.33 | 33 |
| Rowe, Kristina MD | $7.33 | 33 |
| Healy, Paul MD | $7.33 | 31 |
| Gill, Brent MD | $7.33 | 30 |
| Lorio, William MD | $7.33 | 28 |
| Paul, Daniel MD | $7.33 | 28 |
| Abaroa-Salvatierra, Ana M.D. | $7.33 | 27 |
North Carolina Pricing in Context
In North Carolina, CPT code 87184 (Evaluation Of Antimicrobial Drug (antibiotic, Antifungal, Antiviral)) carries an average Medicare payment of $7.31 — 0% below the national benchmark of $7.32. 51 providers across the state submitted claims for this procedure in 2023, performing 1.1K total services. Individual payments in NC ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in North Carolina is $43.65, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because North Carolina sits below the national Medicare average, commercial rates in the state may also run lower than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Drug/Toxicology Test procedures, the estimated commercial insurance price in North Carolina lands near $15.94, with self-pay cash prices typically around $17.49. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Evaluation Of Antimicrobial Drug (antibiotic, Antifungal, Antiviral) cost in North Carolina?
The average Medicare payment for Evaluation Of Antimicrobial Drug (antibiotic, Antifungal, Antiviral) in North Carolina is $7.31, which is 0% below the national average of $7.32. Providers in NC typically bill $43.65 for this procedure.
What does Evaluation Of Antimicrobial Drug (antibiotic, Antifungal, Antiviral) cost with insurance in North Carolina?
With commercial insurance in North Carolina, Evaluation Of Antimicrobial Drug (antibiotic, Antifungal, Antiviral) costs an estimated $15.94. Without insurance, the estimated cash price is $17.49. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Evaluation Of Antimicrobial Drug (antibiotic, Antifungal, Antiviral) in North Carolina?
51 providers in North Carolina billed Medicare for Evaluation Of Antimicrobial Drug (antibiotic, Antifungal, Antiviral) in 2023, performing 1.1K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Evaluation Of Antimicrobial Drug (antibiotic, Antifungal, Antiviral) cheaper in North Carolina than the national average?
Yes — Evaluation Of Antimicrobial Drug (antibiotic, Antifungal, Antiviral) costs 0% below the national average in North Carolina. The state average Medicare payment is $7.31 compared to $7.32 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.